Special Issue "Heated Tobacco Products"

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601).

Deadline for manuscript submissions: 31 December 2021.

Special Issue Editors

Dr. Vaughan W. Rees
E-Mail Website
Guest Editor
Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Kresge, 6th Floor, Boston, MA 02115, USA
Interests: assessment of tobacco product design; potential for dependence; product use and individual risk; secondhand smoke (SHS) exposure
Dr. Mateusz Jankowski
E-Mail Website
Guest Editor
School of Public Health, Centre of Postgraduate Medical Education, Kleczewska 61/63 Str, 01-826 Warsaw, Poland
Interests: tobacco control; tobacco related diseases; e-cigarettes; heated tobacco products; lifestyle medicine; prevention programmes; health policy

Special Issue Information

Dear Colleague,

This Special Issue will focus on the public health implications of heated tobacco products (HTP) – also known as heat-not-burn products. Recent examples of HTPs marketed globally include IQOS (PMI), Glo (BAT), and TECH (JTI). Like other non-combustible nicotine devices, HTPs may produce lower levels of toxic emissions compared with combusted cigarettes, leading to lowered exposure in consumers who switch completely. Nonetheless, there are concerns about the broader public health implications of HTPs, including changes in perception of smoking risk, delay in smoking cessation, dual use with combusted cigarettes, and initiation of tobacco use among youth.

Therefore, a rigorous evidence base is needed to inform the public health community and guide regulatory strategies to ensure that HTPs support tobacco harm reduction objectives. A comprehensive approach to FTP regulation will be founded on cutting-edge science across a range of research topics and disciplines. We invite papers on HTPs that include research on the following: product design analysis; chemical testing (tobacco and smoke analysis); preclinical human testing (perceptions, use behavior, exposure biomarkers); human trials and epidemiological analysis; analysis of advertising, marketing, and health warnings; tax policy; and post-market surveillance. We are also interested in the weight of scientific evidence reviews, and we welcome papers from diverse global settings. By highlighting emerging research on HTPs from leading public health scientists and policy experts, this Special Issue will provide critical evidence to advance tobacco harm reduction and public health policy.

Vaughan W. Rees
Mateusz Jankowski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers
Int. J. Environ. Res. Public Health 2021, 18(19), 10551; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph181910551 - 08 Oct 2021
Viewed by 445
IQOS, the leading heated tobacco product globally, recently received ‘reduced exposure’ authorization from the US Food and Drug Administration. Independent research focusing on IQOS marketing and potential impact on consumers’ perceptions and behavior, and ultimately public health, is critical. The literature to date [...] Read more.
IQOS, the leading heated tobacco product globally, recently received ‘reduced exposure’ authorization from the US Food and Drug Administration. Independent research focusing on IQOS marketing and potential impact on consumers’ perceptions and behavior, and ultimately public health, is critical. The literature to date has underscored several concerns. First, Philip Morris’s (PM’s) marketing distribution requires scrutiny, particularly given its innovative promotional strategies. For example, IQOS is distributed via unique points-of-sale (POS; e.g., specialty and pop-up stores, “corners” in convenience stores) and uses various other opportunities (e.g., social media, sponsored events, direct-to-consumer). Second, although PM claims that IQOS’ target market is current combustible tobacco users and not young people, the literature indicates that in some populations, IQOS use is equally prominent among smokers and nonsmokers, and that specific subgroups (e.g., young adults, women) are targeted. Third, the impact of IQOS’ use of ad content promoting IQOS health benefits must be studied (e.g., how consumers interpret modified exposure messages). In conclusion, surveillance of IQOS marketing, particularly following reduced exposure authorization, is critical for obtaining valuable data to estimate population impact, particularly among population subgroups (e.g., young adults), and inform future tobacco regulation. These considerations have implications beyond IQOS—to other products and companies. Full article
(This article belongs to the Special Issue Heated Tobacco Products)
Show Figures

Figure 1

Back to TopTop